Objective To describe preterm birth frequency and newborn and infant outcomes overall and among preterm children in the MATISSE (Maternal Immunization Study for Safety and Efficacy) trial of maternal vaccination with bivalent respiratory syncytial virus (RSV) prefusion F protein–based vaccine (RSVpreF) to protect infants against severe RSV-associated illness. Methods MATISSE was a global, phase 3, […]

Latest updates

From the Nigeria team

11 OCT

Nigeria’s newborn deaths have barely moved in a decade. A maternal vaccine could help, if the country is ready

Professor Hadiza Galadanci was the first female obstetrician trained in Nigeria’s Kano region, and she has spent close to four decades combining frontline clinical work with research that has shaped policy across West Africa.   She holds an MBBS from Ahmadu Bello University, a Master’s in Reproductive and Sexual Health Research from University College London, […]

Language access

View MIRNA content in your preferred language.

Use the language selector in the website header to translate MIRNA content across the site.

English · Kiswahili · Amharic · Bangla · Urdu · French

Partners

Nigeria network partners

Partner directory

Nigeria

Explore resources from Nigeria

Nigeria projects

Preterm Birth Frequency and Associated Outcomes From the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Trial of the Bivalent Respiratory Syncytial Virus Prefusion F Protein Vaccine

From the Nigeria team

View MIRNA content in your preferred language.

Nigeria network partners

MIRNA updates, evidence and opportunities